shutterstock_1399766828_jisoo_song
12 December 2023FeaturesAsiaYoung Kim, Yu-Seog WON, In Hwan Kim and Amy (Seung-Hyun) Oh

Why did a South Korea court invoke the ‘extraterritorial activity’ exception in Prevenar 13 case?

In a patent infringement action filed by Pfizer, the Seoul Central District Court rendered a decision finding that another pharmaceutical company directly infringed Pfizer's composition patent—even though the infringer did not make the patented composition in Korea.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
27 May 2026   China’s IP system is undergoing real change. Takeda’s IP head for the region explains what that looks like on the ground and why the old playbook no longer cuts it.
Asia
20 May 2026   Backed by the country’s wider AI ambitions, Google has signed a deal to roll out healthcare, scientific research, and safety initiatives.
Asia
31 March 2026   The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.